2023
Pediatric renal malignancy diagnosis is associated with significant burden of care for families
Leraas H, Thompson S, Sandoe E, Robles J, Wagner L, Scales C, Gow K, Ehrlich P, Greenup R, Tracy E. Pediatric renal malignancy diagnosis is associated with significant burden of care for families. Pediatric Blood & Cancer 2023, 70: e30494. PMID: 37337248, DOI: 10.1002/pbc.30494.Peer-Reviewed Original ResearchHealthcare utilizationRenal malignancySolid tumor diagnosisNorth Carolina MedicaidComplex care coordinationBurden of careChildhood cancer diagnosisRenal tumor diagnosisTumor diagnosisSubsequent nephrectomyMedian ageStudy criteriaCare coordinationRenal tumorsCancer regimensPatient visitsDiseases codesMalignancy diagnosisInternational ClassificationSignificant burdenMedical careDiagnosisCancer diagnosisMonthsMedical facilities
2017
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer
Gamble C, Havrilesky L, Myers E, Chino J, Hollenbeck S, Plichta J, Kelly Marcom P, Shelley Hwang E, Kauff N, Greenup R. Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer. Annals Of Surgical Oncology 2017, 24: 3116-3123. PMID: 28699130, PMCID: PMC5990891, DOI: 10.1245/s10434-017-5995-z.Peer-Reviewed Original ResearchConceptsRisk-reducing mastectomyOvarian cancer diagnosisIncremental cost-effectiveness ratioBRCA mutation carriersMonths of lifeMutation carriersMagnetic resonance imagingCancer diagnosisSurvival benefitOvarian cancerMutation statusMost BRCA1/2 mutation carriersThird-party payer perspectiveGreater survival benefitBreast cancer riskBRCA mutation statusBRCA1/2 mutation carriersBRCA2 mutation carriersBRCA2 mutation statusBRCA1 mutation carriersBreast cancer screeningMonte Carlo probabilistic sensitivity analysisCost-effectiveness ratioYears of lifeProbabilistic sensitivity analyses